Rohan Palekar - 08 Sep 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol
ETNB
Transactions as of
08 Sep 2022
Transactions value $
$193,000
Form type
4
Filing time
09 Sep 2022, 16:39:18
Previous filing
16 May 2022
Next filing
30 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $193K +100K +102.43% $1.93* 198K 08 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -100K -30.75% $0.00 225K 08 Sep 2022 Common Stock 100K $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2022.
F2 This option is vested in full.